Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: An outstanding candidate marker to predict the response to endocrine therapy

Cancer Research

Volumn 61, Issue 4, 2001, Pages 1652-1658

  Bièche, Ivan ^a,b   Parfait, Béatrice ^a   Le Doussal, Vivianne ^c   Olivi, Martine ^a   Rio, Marie Christine ^d   Lidereau, Rosette ^b   Vidaud, Michel ^a  

^a FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

^b Centre René Huguenin   (United States)

^c Centre René Huguenin   (United States)

^d INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN ALPHA SUBUNIT; ESTROGEN; ESTROGEN RECEPTOR; PROGESTERONE; TAMOXIFEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GRADING; CANCER HORMONE THERAPY; DNA SYNTHESIS; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CYCLIN D1; CYTOPLASM; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; HUMANS; MIDDLE AGED; PROGNOSIS; PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 0035866350     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Steroid hormone receptors in breast cancer treatment strategy
2. William L. McGuire Memorial Lecture. Antiestrogens: Mechanisms of action and resistance in breast cancer
3. The pS2/TFF1 trefoil factor, from basis research to clinical applications
4. Prognostic value of chorionic gonadotropin β gene transcripts in human breast carcinoma
5. Histological grading and prognosis in breast cancer
6. Revision of the standards of the assessment of hormone receptors in human breast cancer. Report of the second EORTC Workshop
7. Antigenic determinants on human choriogonadotropin α-subunit. I. Characterization of topographic sites recognized by monoclonal antibodies
8. Nonparametric estimation from incomplete observations
9. Quantitation of myc gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay
10. Real-time reverse transcription PCR assay for future management of ERBB2-based clinical applications
11. A novel method for real time quantitative RT-PCR
12. Significance of α-subunit HCG demonstrated in breast carcinomas by the immunoperoxidase technique
13. Presence of functional luteinizing hormone/chorionic gonadotropin (hCG) receptors in human breast cell lines: Implications supporting the premise that hCG protects women against breast cancer
14. Luteinizing hormone/human chorionic gonadotropin receptors in breast cancer
15. Loss of tumorigenic potential by human lung tumor cells in the presence of antisense RNA specific to the ectopically synthesized α subunit of human chorionic gonadotropin
16. Induction of pituitary lactotrope differentiation by luteinizing hormone α subunit
17. The myometrium of postmenopausal women produces prolactin in response to human chorionic gonadotropin and α-subunit in vitro
18. Free α molecules from pregnancy stimulate secretion of prolactin from human decidual cells: A novel function for free α in pregnancy
19. Should prolactin be reconsidered as a therapeutic target in human breast cancer?
20. Regulation of chorionic gonadotropin gene expression
21. Molecular basis of agonism and antagonism in the oestrogen receptor
22. Estrogen induction of the cyclin D1 promoter: Involvement of a cAMP response-like element
23. Estradiol inhibits transcription of the human glycoprotein hormone α-subunit gene despite the absence of a high affinity binding site for estrogen receptor